Institut Curie
Clinical trials sponsored by Institut Curie, explained in plain language.
-
Experimental drug tested for Tough-to-Treat breast cancer
Disease control TerminatedThis study tested an experimental drug called PLX038 for people with advanced triple-negative breast cancer that had stopped responding to other treatments. Participants received the drug through an IV every three weeks to see if it could shrink their tumors. The trial was termin…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug tested for tough blood cancers in older adults
Disease control TerminatedThis study tested an experimental drug called PF-05212384 for people with aggressive forms of blood cancer, including acute myeloid leukemia (AML) that had returned or didn't respond to other treatments, or AML that developed as a side effect of prior cancer therapy. The goal was…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Terminated cancer drug combo trial sought right dose
Disease control TerminatedThis early-stage trial aimed to find a safe and effective dose for combining two oral cancer drugs (tuvusertib and PLX038) in patients with advanced solid tumors that had stopped responding to standard treatments. The study first tested different dose combinations in a small grou…
Phase: PHASE1 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Blood test research aims to spot cervical cancer spread earlier
Knowledge-focused TerminatedThis study aimed to see if tracking tiny pieces of cancer-related DNA from the HPV virus in the blood could help monitor cervical cancer and detect its spread sooner. Researchers enrolled 26 patients with cervical cancer to test new lab methods for finding this DNA. The goal was …
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC